Over Half of ALK-Positive NSCLC Patients Responded To Crizotinib In Colorado Study
Lasofoxifene Reduced Breast Cancer Risk In Postmenopausal Osteoporotic Women
Patients Prefer Silicone Over Saline Implants
More Breast Cancer Patients Opt To Remove Both Breasts
Small Study: Radiation, Chemo May Better Control Anal Cancer
BRAF Inhibitor Shrank Tumors In Phase II Genentech Study
Colorectal Cancer Risk Rises In ADT Use In Prostate Cancer
Radiotherapy Plus Cetuximab May Control Head/Neck Cancer
Clinical Trials Approved By NCI
Trending Stories
- DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - Karen Knudsen tells us why she took the CEO job at the Parker Institute for Cancer Immunotherapy
- Brian Druker, developer of Gleevec, eyes a new feat: Setting the Boston Marathon fundraising record
Current record: $507,000. Proceeds to go to LLS as NIH funding is slashed - What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - Amid HHS upheaval, Bhattacharya takes the helm at NIH, Makary at FDA
Meanwhile, NASEM sounds “SOS” for health infrastructure - Alec Kimmelman announced as next CEO and Dean of NYU Langone Health
